Allogeneic stem cell transplantation with reduced intensity conditioning in lymphoproliferative disorders

被引：0

作者：

Vigouroux, S. ^{[1
]}

机构：

[1] CHU Bordeaux, Hop Haut Leveque, Serv Malad Sang, F-33600 Pessac, France

来源：

ONCOLOGIE | 2011年 / 13卷 / 09期

关键词：

Reduced-conditioning allogeneic stem cell transplantation; Multiple myeloma; Follicular lymphoma; Diffuse large B-cell lymphoma; Peripheral T-cell lymphoma; TERM-FOLLOW-UP; ADVANCED FOLLICULAR LYMPHOMA; BONE-MARROW-TRANSPLANTATION; NEWLY-DIAGNOSED MYELOMA; NOVO MULTIPLE-MYELOMA; NON-HODGKINS-LYMPHOMA; LOW-GRADE LYMPHOMA; PERIPHERAL T-CELL; AUTOLOGOUS TRANSPLANTATION; EUROPEAN GROUP;

D O I：

10.1007/s10269-011-2064-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The role of reducedintensity allogeneic stem cell transplantation in lymphoid hematologic malignancies is not consensual and remains difficult to define mainly because of lack of comparative studies. In myeloma, the topic is extremely controversial in first-line therapy and in more advanced disease. It seems that the procedure might be beneficial in relapsed chemosensitive diffuse large B-cell lymphoma and in advanced follicular lymphoma. In peripheral T-cell lymphoma, the promising results in relapse have stimulated efforts to evaluate allogeneic transplants in first line. However, it is important to note that because of many uncertainties surrounding allogeneic stem cell transplantation in lymphoid malignancies, the best transplant strategy would be to include patients in clinical trials whenever possible. To cite this journal: Oncologie 13 (2011).

引用

页码：559 / 564

页数：6

共 30 条

[1] Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study [J].

Bethge, Wolfgang A. ;

Lange, Thoralf ;

Meisner, Christoph ;

von Harsdorf, Stephanie ;

Bornhaeuser, Martin ;

Federmann, Birgit ;

Stadler, Michael ;

Uharek, Lutz ;

Stelljes, Matthias ;

Knop, Stefan ;

Wulf, Gerald ;

Trenschel, Rudolf ;

Vucinic, Vladan ;

Dittmann, Helmut ;

Faul, Christoph ;

Vogel, Wichard ;

Kanz, Lothar ;

Bunjes, Donald .

BLOOD, 2010, 116 (10) :1795-1802

[2] A comparison of allografting with autografting for newly diagnosed myeloma [J].

Bruno, Benedetto ;

Rotta, Marcello ;

Patriarca, Francesca ;

Mordini, Nicola ;

Allione, Bernardino ;

Carnevale-Schianca, Fabrizio ;

Giaccone, Luisa ;

Sorasio, Roberto ;

Omede, Paola ;

Baldi, Ileana ;

Bringhen, Sara ;

Massaia, Massimo ;

Aglietta, Massimo ;

Levis, Alessandro ;

Gallamini, Andrea ;

Fanin, Renato ;

Palumbo, Antonio ;

Storb, Rainer ;

Ciccone, Giovannino ;

Boccadoro, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (11) :1110-1120

[3] Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells [J].

Corradini, P ;

Dodero, A ;

Zallio, F ;

Caracciolo, D ;

Casini, M ;

Bregni, M ;

Narni, F ;

Patriarca, F ;

Boccadoro, M ;

Benedetti, F ;

Rambaldi, A ;

Gianni, AM ;

Tarella, C .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2172-2176

[4] Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma [J].

Garban, F ;

Attal, M ;

Michallet, M ;

Hulin, C ;

Bourhis, JH ;

Yakoub-Agha, I ;

Lamy, T ;

Marit, G ;

Maloisel, F ;

Berthou, C ;

Dib, M ;

Caillot, D ;

dePrijck, B ;

Ketterer, N ;

Harousseau, JL ;

Sotto, JJ ;

Moreau, P .

BLOOD, 2006, 107 (09) :3474-3480

[5] Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma [J].

Giaccone, Luisa ;

Storer, Barry ;

Patriarca, Francesca ;

Rotta, Marcello ;

Sorasio, Roberto ;

Allione, Bernardino ;

Carnevale-Schianca, Fabrizio ;

Festuccia, Moreno ;

Brunello, Lucia ;

Omede, Paola ;

Bringhen, Sara ;

Aglietta, Massimo ;

Levis, Alessandro ;

Mordini, Nicola ;

Gallamini, Andrea ;

Fanin, Renato ;

Massaia, Massimo ;

Palumbo, Antonio ;

Ciccone, Giovannino ;

Storb, Rainer ;

Gooley, Ted A. ;

Boccadoro, Mario ;

Bruno, Benedetto .

BLOOD, 2011, 117 (24) :6721-6727

[6] Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma:: An East German Study Group hematology and oncology study [J].

Herold, Michael ;

Haas, Antje ;

Srock, Stefanie ;

Neser, Sabine ;

Al-Ali, Kathrin Haifa ;

Neubauer, Andreas ;

Doelken, Gottfried ;

Naumann, Ralph ;

Knauf, Wolfgang ;

Freund, Mathias ;

Rohrberg, Robert ;

Hoeffken, Klaus ;

Franke, Astrid ;

Ittel, Thomas ;

Kettner, Erika ;

Haak, Ursula ;

Mey, Ulrich ;

Klinkenstein, Christian ;

Assmann, Michael ;

von Gruenhagen, Ullrich .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :1986-1992

[7] Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group [J].

Hiddemann, W ;

Kneba, M ;

Dreyling, M ;

Schmitz, N ;

Lengfelder, E ;

Schmits, R ;

Reiser, M ;

Metzner, B ;

Harder, H ;

Hegewisch-Becker, S ;

Fischer, T ;

Kropff, M ;

Reis, HE ;

Freund, M ;

Wörmann, B ;

Fuchs, R ;

Planker, M ;

Schimke, J ;

Eimermacher, H ;

Trümper, L ;

Aldaoud, A ;

Parwaresch, R ;

Unterhalt, M .

BLOOD, 2005, 106 (12) :3725-3732

[8] Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality [J].

Khouri, IF ;

Saliba, RM ;

Giralt, SA ;

Lee, MS ;

Okoroji, GJ ;

Hagemeister, FB ;

Korbling, M ;

Younes, A ;

Ippoliti, C ;

Gajewski, JL ;

McLaughlin, P ;

Anderlini, P ;

Donato, ML ;

Cabanillas, FF ;

Champlin, RE .

BLOOD, 2001, 98 (13) :3595-3599

[9] Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab [J].

Khouri, Issa F. ;

McLaughlin, Peter ;

Saliba, Rima M. ;

Hosing, Chitra ;

Korbling, Martin ;

Lee, Ming S. ;

Medeiros, L. Jeffrey ;

Fayad, Luis ;

Samaniego, Felipe ;

Alousi, Amin ;

Anderlini, Paolo ;

Couriel, Daniel ;

de Lima, Marcos ;

Giralt, Sergio ;

Neelapu, Sattva S. ;

Ueno, Naoto T. ;

Samuels, Barry I. ;

Hagemeister, Fredrick ;

Kwak, Larry W. ;

Champlin, Richard E. .

BLOOD, 2008, 111 (12) :5530-5536

[10] Mini-Midi-Maxi?: How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation [J].

Kroeger, N. .

LEUKEMIA, 2007, 21 (09) :1851-1858

← 1 2 3 →